Understanding Gestational Diabetes in Asian Pregnant Women
Official title: Studying the Heterogeneity of Gestational Diabetes Mellitus: Cardio-Metabolic Alteration and Treatment Response in a Multi-Ethnic Population in Singapore (GDM-CARE)
Run by National University Health System, Singapore · NCT06542718 · Data updated 2026-11-12
This study is trying to learn more about gestational diabetes in Asian pregnant women to see how different types of the condition affect their health and treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 45 Years |
| Sex | Women only |
| Enrollment | 800 (estimated) |
| Sponsor | National University Health System, Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | October 3, 2022 |
| Main results expected | June 30, 2026 |
| Study ends | July 1, 2026 |
| Registry record updated | May 28, 2025 |
| Trial ID | NCT06542718 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are overweight or obese pregnant women of Chinese, Malay, or Indian ethnicity, aged 21-45, who are within the first trimester of pregnancy.
✕Probably not a fit
Patients who are not Singapore citizens or permanent residents, or those with a history of Type 1 or Type 2 diabetes, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on gestational diabetes mellitus (GDM), a condition that affects pregnant women and can lead to serious health issues for both mothers and babies. It aims to identify different phenotypes of GDM among Asian women by analyzing their cardio-metabolic profiles and treatment responses during pregnancy. Utilizing advanced technologies like continuous glucose monitoring and metabolite profiling, the study seeks to provide insights that could lead to more personalized treatment strategies for managing GDM. By understanding the heterogeneity of GDM, the researchers hope to improve clinical outcomes for affected mothers and their children.
Why it matters
Potential benefit: If successful, this study could lead to more effective and tailored treatment strategies for managing gestational diabetes in pregnant women.
How similar studies have gone: While the approach of defining GDM phenotypes is innovative, similar studies have shown promise in understanding the complexities of gestational diabetes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational age of ≤ 13 weeks 6 days * Overweight and obese subjects with BMI of 23kg/m² - 24.9kg/m² and ≥ 25.0kg/m², respectively * Aged 21-45 years with singleton pregnancy * Plan to be followed up during the whole pregnancy and deliver at NUH * Chinese, Malay or Indian ethnicity for pregnant subject * Can complete questionnaires in English language * Willing to wear continuous glucose monitoring device at least for 7 days at each required clinic visit Exclusion Criteria: * Participants who are not Singapore citizens or Singapore Permanent Residents, not intending to eventually deliver in Singapore National University Hospital and to reside in Singapore for the next 2 years * Have serious skin conditions (eg. eczema) that precludes wearing the sensor for 14 days * With history of Type 1 diabetes or Type 2 diabetes * With chronic preexisting life-threatening conditions including pancreatic cancer, end-stage kidney dysfunction, and psychosis * Unable to read or speak English
Where it's running
-
Department of Obstetrics & Gynaecology
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Ling-Jun Li, MD, PhD
- Email: obgllj@nus.edu.sg
- Phone: 81000229
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Real-time glucose monitoring with group support during pregnancy
This program will test whether wearing a real-time glucose monitor and joining a group chat helps pregnant people at risk for gestational diabetes keep their blood sugar in a healthy range.
-
Delivering HOPE: healthy food and grocery support during pregnancy
This project will test whether providing pregnant people with healthy food and grocery funds during pregnancy reduces excessive weight gain compared with enhanced usual care.
-
Examining how aspirin metabolism relates to metabolic dysfunction in pregnant individuals at risk of preeclampsia
This study is trying to see how the way pregnant people process aspirin relates to their metabolic health and the health of their babies, especially for those at risk of preeclampsia.
-
Comparing early and late blood glucose monitoring in pregnant women with a history of gestational diabetes
This study tests if pregnant women with a history of gestational diabetes do better when they monitor their blood sugar early in pregnancy instead of waiting until later.
-
Comparing strict and permissive thresholds for treating gestational diabetes
This study is testing whether treating gestational diabetes with stricter or more relaxed blood sugar targets leads to better health outcomes for mothers and their babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.